Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRR | Q9GZT4 | 2/20 | 0.55 |
| ▸ | PSAT1 | Q9Y617 | 2/20 | 0.55 |
| ▸ | PPARG | P37231 | 8/20 | 0.50 |
| ▸ | PPARA | Q07869 | 6/20 | 0.50 |
| ▸ | MME | P08473 | 4/20 | 0.49 |
| ▸ | ACE | P12821 | 4/20 | 0.49 |
| ▸ | CPA1 | P15085 | 2/20 | 0.49 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.49 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.47 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | ACACB | O00763 | 1/20 | 0.47 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28237997 | 0.90 | SLC6A2 (0.50) | SRRTSHRPTGS1 | |
| SCHEMBL1811694 | 0.90 | SLC6A2 (0.50) | SRRTSHRPTGS1 | |
| SCHEMBL28914994 | 0.90 | SLC6A2 (0.50) | SRRTSHRPTGS1 | |
| SCHEMBL8716757 | 0.85 | MMP12 (0.56) | SRRPSAT1PPARGPPARAMME | |
| SCHEMBL22474260 | 0.84 | SRR (0.53) | SRRPSAT1PPARGPPARAMME | |
| SCHEMBL2747604 | 0.83 | TAAR1 (0.53) | LMNATSHR | |
| SCHEMBL2561209 | 0.83 | NPC1 (0.45) | LMNATSHRPTGS1 | |
| SCHEMBL9136582 | 0.83 | PPARG (0.44) | PPARGPPARAFFAR1ACACBLMNA | |
| SCHEMBL2747602 | 0.83 | TAAR1 (0.53) | LMNATSHR | |
| SCHEMBL113258 | 0.83 | PPARA (0.44) | PPARGPPARALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 759 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008013427-A1 | ORGANIC TFTS AND METHOD FOR FABRICATING THE SAME | LG CHEM, LTD. (KR) | 2008-01-31 | — | — | WO | claimed |
| WO-2007056455-A2 | N-PROTECTED AMINOINDANES AND METHODS OF THEIR PREPARATION | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2007-05-18 | — | — | WO | claimed |
| WO-2026107134-A1 | USE OF SMALL MOLECULE GLUTAMINASE INHIBITORS FOR TREATING AGE-RELATED DISORDERS | LEAL THERAPEUTICS, INC. (US) | 2026-05-21 | — | — | WO | disclosed |
| EP-4724418-A1 | TRICINE AND CITRIC ACID-BASED CATIONIC LIPIDS | Sanofi (FR) | 2026-04-15 | — | — | EP | disclosed |
| WO-2025151874-A1 | INDOLE ALKALOID ANTIPLASMODIAL AGENTS AND PREPARATION THEREOF | UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) | 2025-07-17 | — | — | WO | disclosed |
| WO-2025104706-A2 | SMALL MOLECULE MODULATORS OF MAS AND MRGD RECEPTORS | XITRA THERAPEUTICS GMBH (DE) | 2025-05-22 | — | — | WO | disclosed |
| EP-4554671-A1 | CYCLIC PEPTIDE INHIBITORS OF IL-23 | JANSSEN Pharmaceutica NV (BE) | 2025-05-21 | — | — | EP | disclosed |
| EP-4486336-A2 | CB1 LIGAND CONJUGATED COMPOUNDS AND USES THEREOF | Adarx Pharmaceuticals, Inc. (US) | 2025-01-08 | — | — | EP | disclosed |
| WO-2025003759-A1 | DIANHYDROHEXITOL BASED IONIZABLE LIPIDS FOR NUCLEIC ACID DELIVERY | SANOFI (FR) | 2025-01-02 | — | — | WO | disclosed |
| EP-4475837-A2 | TRKB LIGAND CONJUGATED COMPOUNDS AND USES THEREOF | Adarx Pharmaceuticals, Inc. (US) | 2024-12-18 | — | — | EP | disclosed |
| US-12054570-B2 | Functional oligomers and functional polymers including hydroxylated polymers and conjugates thereof and uses thereof | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2024-08-06 | — | — | US | disclosed |
| EP-0730570-A1 | METHOD FOR MAKING INTERMEDIATES USEFUL IN SYNTHESIS OF RETROVIRAL PROTEASE INHIBITORS | G.D. SEARLE & CO. (US) | 1996-09-11 | — | — | EP | disclosed |
| WO-1996022275-A1 | METHOD OF PREPARING RETROVIRAL PROTEASE INHIBITOR INTERMEDIATES | G.D. SEARLE & CO. (US) | 1996-07-25 | — | — | WO | disclosed |
| WO-1996011943-A1 | NEW PEPTIDES WITH IMMUNOMODULATORY EFFECTS | ASTRA AKTIEBOLAG (SE) | 1996-04-25 | — | — | WO | disclosed |
| US-5506355-A | REACTING DIAMINE HAVING DIOL PROTECTED WITH CYCLIC ACETAL GROUP IN SOLVENT WITH HINDERED AMINE BASE AND SULFONYL GROUP PRECURSOR, ALKYLATING IN PRESENCE OF BASE | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-04-09 | — | — | US | disclosed |
| EP-0651761-A1 | METHOD FOR MODIFICATION OF RECOMBINANT POLYPEPTIDES | BIONEBRASKA, INC. (US) | 1995-05-10 | — | — | EP | disclosed |
| WO-1994001451-A2 | METHOD FOR MODIFICATION OF RECOMBINANT POLYPEPTIDES | BIONEBRASKA, INC. (US) | 1994-01-20 | — | — | WO | disclosed |
| EP-0222889-A4 | CYTIDINE ANALOGS. | INTEGRATED GENETICS INC (US) | 1988-09-28 | — | — | EP | disclosed |
| EP-0222889-A1 | CYTIDINE ANALOGS. | INTEGRATED GENETICS INC (US) | 1987-05-27 | — | — | EP | disclosed |
| WO-1986006726-A1 | CYTIDINE ANALOGS | INTEGRATED GENETICS, INC. (US) | 1986-11-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12054570-B2 | Functional oligomers and functional polymers including hydroxylated polymers and conjugates thereof and uses thereof | PUF60, PGLS, PARG | SRR 2941/4885PSAT1 920/4885PPARG 4090/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.